BrightSpring Health Services, Inc. Reports Third Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
BrightSpring posted Q3 2026 revenue of $4,213 million, up 26.4% year-over-year, with net income from continuing operations of $101 million versus $38 million a year ago. Adjusted EBITDA rose 42% to $228 million, and leverage improved to 1.79x from 2.15x at June 30, 2026, after the March divestiture of the Community Living business.
Key figures
- Eps
- 0.46
- Revenue
- 4213234000
- Guidance
- FY26 revenue $15,900M-$16,125M (23.2%-24.9% growth); Adjusted EBITDA $850M-$860M (37.6%-39.3% growth), raised
- Revenue Yoy
- 26.4%
- Leverage
- 1.79x
- Adjusted eps
- 0.54
- Gross profit
- 519000000
- Adjusted ebitda
- 228000000
- Gross profit yoy
- 32.3%
- Adjusted ebitda yoy
- 42.0%
- Net income continuing ops
- 101000000
- Provider services revenue
- 481000000
- Pharmacy solutions revenue
- 3732000000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.